Health news
Health news top Health news

   Login  |  Register    
Health News Make AMN Your Home PageDiscussion BoardsAdvanced Search ToolMedical RSS/XML News FeedHealth news
  You are here : Health.am > Health Centers > Public Health -
FDA staff questions value of breast implant data FDA staff questions value of breast implant data

FDA staff questions value of breast implant data

Public HealthApr 07, 2005

New data from Inamed Corp. and rival Mentor Corp. on their silicone breast implants are of “limited value” in assessing the risk of ruptures, U.S. regulatory staff said in reports made public on Wednesday.

The Food and Drug Administration released the staff evaluations ahead of a three-day advisory panel meeting next week on whether silicone breast implants should return to the market after they were banned for most women in 1992 over health concerns.

Many women and plastic surgeons say the silicone devices have a more natural look and feel than saline-filled breast implants.

Although studies have failed to find a link between silicone implants and chronic diseases such as cancer, lupus and Rheumatoid Arthritis, some are convinced that leaking silicone can cause sickness.

“These data are of limited value to address the rupture rate over the lifetime of the device due to the short duration of follow-up,” the FDA staff wrote about Mentor’s information, adding it was also “of limited value to address the local health consequences of rupture due to the small number of ruptures observed.”

The reviewers made similar comments about studies by Inamed, which is being acquired by Medicis Pharmaceutical Corp.

Officials for both companies could not immediately be reached for comment.

Inamed shares were off $1.12 at $66.98 in early afternoon trading on Nasdaq. Medicis shares were off 81 cents at $28.82 and Mentor shares were up 2 cents at $32.78, both on the New York Stock Exchange.

Provided by ArmMed Media
Revision date: July 6, 2011
Last revised: by David A. Scott, M.D.

FDA staff questions value of breast implant data Bookmark this! FDA staff questions value of breast implant data

RELATED STORIES:


 Comments [ + Post Your Own

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]




We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.

All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

Please enter the word you see in the image below:


   [advanced search]   
What health info have you recently searched for online?
Disease or condition
Exercise or fitness
Diet, nutrition or vitamins
None of the above


Get free support - Headache Causes, Symptoms, Diagnosis, and Treatment on HeadacheCare.net


Health Centers







Diabetes

















Health news
  


Health Encyclopedia

Diseases & Conditions

Drugs & Medications

Health Tools

Health Tools



   Health newsletter

  





   Medical Links



   RSS/XML News Feed



   Feedback


Add to Yahoo RSS News Feed



Google Reader




Syndicate


This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information:
Verify here.




Ovantra: Put the SEX Drive Back into your marriage